FdaApplication
BLA 761394
Identifiers
- fda_app_no: BLA761394
Properties
| Property | Value |
|---|---|
| applicant_name | Daiichi Sankyo, Inc |
| application_type | BLA |
| approval_date | 2025-01-17 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DATROWAY | DATOPOTAMAB DERUXTECAN-DLNK | 100MG | INJECTABLE;IV (INFUSION) |
1 product